MedTrace Logo

Injectable Filler for Cheek Flattening

NCT01225354 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2020-12-16

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine if Radiesse injections to the cheeks result in an altered and improved first impression and self esteem.

Conditions

  • Malar Deficiency

Interventions

DRUG

Calcium hydroxylapatite

Subjects will be treated to full correction at visit 1 and, if needed, a touch-up injection at 2 weeks.

Sponsors & Collaborators

  • Merz Aesthetics Inc.

    collaborator INDUSTRY

  • DeNova Research

    lead OTHER

Principal Investigators

  • Steven H Dayan, MD · DeNova Research/ Chicago Center for Facial Plastic Surgery

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2011-08-31
Completion
2011-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01225354 on ClinicalTrials.gov